Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

6.98
BATS BZX Real-Time Price
As of 10:59am ET
 -0.32 / -4.38%
Today’s Change
3.11
Today|||52-Week Range
9.93
+73.20%
Year-to-Date

Today’s Trading

Previous close7.30
Today’s open7.23
Day’s range6.94 - 7.23
Volume7,006
Average volume (3 months)500,992
Market cap$292.0M
Dividend yield--
Data as of 10:59am ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+10.59%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-55.97%
P/E ratioNM
Price/Sales28.75
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.16+8.33%
NBRVNabriva Therapeutics...+0.01+0.10%
PETXAratana Therapeutics...-0.03-0.42%
AVEOAveo Pharmaceuticals...-0.10-3.89%
Data as of 11:03am ET, 07/25/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$5.1M
Annual profit (last year)-$77.5M
Net profit margin-1,505.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Principal Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts